Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia
Crossref DOI link: https://doi.org/10.1007/s00277-014-2124-y
Published Online: 2014-06-07
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Aldoss, Ibrahin
Mark, Lisa
Vrona, Janice
Ramezani, Laleh
Weitz, Ilene
Mohrbacher, Ann M.
Douer, Dan
Text and Data Mining valid from 2014-06-07